4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001256153-25-000004
CEO acquired 71,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEVIN JEREMY M CEO | 2025-12-15 | Conversion | +71,000 | 3,687,715 | D | ||
| Derivatives | |||||||
| LEVIN JEREMY M CEO | 2025-12-11 | Purchase · Series B Convertible Preferred Stock | +71 | 71 | D | ||
| LEVIN JEREMY M CEO | 2025-12-11 | Purchase · Series A Warrant (right to buy) | +47,333 | 47,333 | D | ||
| LEVIN JEREMY M CEO | 2025-12-11 | Purchase · Series B Warrant (right to buy) | +35,500 | 35,500 | D | ||
| LEVIN JEREMY M CEO | 2025-12-15 | Conversion · Series B Convertible Preferred Stock | −71 | 0 | D | ||
Loading xslF345X05/form4-12182025_041203.xml…